[1]
«Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study», AJBR, libk. 22, zenb. 3, or. 347–352, abe. 2019, Eskuratua: 2026(e)ko ekainaren 26(e)an. [Sarean]. Available at: https://ojshostng.com/index.php/ajbr/article/view/1335